A New Jersey drugmaker ensnared in the fallout from America’s opioid crisis is seeking bankruptcy protection. Mallinckrodt said Monday that it had begun Chapter 11 proceedings to restructure debt and resolve “several billion dollars of otherwise unmanageable potential legal liabilities.” The drugmaker, one of the highest-volume opioid producers in the […]